Federal Appeals Court Ruling Affirms Amneal Pharmaceuticals’s Green Light to Market New Esomeprazole Strontium Delayed-Release Capsules

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals LLC today applauded the December 19 decision by the U.S. Court of Appeals for the Federal Circuit (CAFC) in favor of South Korea-based Hanmi Pharmaceutical Co. Ltd. that AstraZeneca PLC’s patents do not cover Hanmi’s Esomeprazole strontium delayed-release capsules.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC